ARTICLE | Emerging Company Profile
Corporate Profile
April 23, 2007 7:00 AM UTC
Paris, France
Technology: Adjuvants for prophylactic and therapeutic vaccines based on natural killer T cell stimulation...
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Paris, France
Technology: Adjuvants for prophylactic and therapeutic vaccines based on natural killer T cell stimulation...